501 – 510 of 592
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog)
2015)(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Tumour hypoxia and the hypoxia inducible transcription factors: Key players in cancer progression and metastasis
2015) p.65-98(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Quantitative imaging by automated bone scan index (BSI) as a response biomarker in standard clinical care of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide
2015) American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium In Journal of Clinical Oncology 33(7 Suppl). p.288-288(
- Contribution to journal › Published meeting abstract
-
Mark
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
(
- Contribution to journal › Article
-
Mark
Gpr116 Receptor Regulates Distinctive Functions in Pneumocytes and Vascular Endothelium.
(
- Contribution to journal › Article
-
Mark
The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
(
- Contribution to journal › Article
-
Mark
A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
(
- Contribution to journal › Article
- 2014
-
Mark
Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia.
(
- Contribution to journal › Article